Placental drug transporters and their role in fetal protection

Placenta

Volumn 33, Issue 3, 2012, Pages 137-142

  Iqbal, M ^a   Audette, M C ^a   Petropoulos, S ^c   Gibb, W ^d   Matthews, S G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Breast cancer resistance protein; Fetal protection; Multidrug resistance; P Glycoprotein

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIRETROVIRUS AGENT; AROMATIC HYDROCARBON RECEPTOR; BETAMETHASONE; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; CCAAT ENHANCER BINDING PROTEIN; CHEMICAL TERATOGEN; CORTICOSTEROID; DEXAMETHASONE; ESTROGEN; GLIBENCLAMIDE; GLUCOCORTICOID; GLYCOPROTEIN P; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR; STAT PROTEIN; STEROID HORMONE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; XENOBIOTIC AGENT;

ARTICLE; BEHAVIOR DISORDER; DRUG TRANSPORT; EPIGENETICS; FETUS; FETUS MALFORMATION; GENETIC REGULATION; GENETIC VARIABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HORMONAL REGULATION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE GROWTH RETARDATION; INTRAUTERINE INFECTION; LOW BIRTH WEIGHT; NEONATAL BEHAVIORAL SYNDROME; NEWBORN DISEASE; PHARMACOGENETICS; PLACENTAL TRANSFER; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SINGLE NUCLEOTIDE POLYMORPHISM; SYNCYTIOTROPHOBLAST; TATA BOX; TERATOGENICITY; TRANSCRIPTION INITIATION SITE;

ANIMALS; BIOLOGICAL TRANSPORT; FEMALE; FETAL DISEASES; FETUS; HUMANS; MATERNAL-FETAL EXCHANGE; MEMBRANE TRANSPORT PROTEINS; PHARMACEUTICAL PREPARATIONS; PLACENTA; PREGNANCY;

EID: 84856972106     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2012.01.008     Document Type: Article

References (87)

1. R.L. Juliano, and V. Ling A surface glycoprotein modulating drug permeability in chinese hamster ovary cell mutants Biochim Biophys Acta 455 1 1976 152 162
2. N. Kartner, J.R. Riordan, and V. Ling Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines Science 221 4617 1983 1285 1288 (Pubitemid 13005502)
3. L.A. Doyle, W. Yang, L.V. Abruzzo, T. Krogmann, Y. Gao, and A.K. Rishi A multidrug resistance transporter from human MCF-7 breast cancer cells Proc Natl Acad Sci U S A 95 26 1998 15665 15670 (Pubitemid 29018757)
4. F. Thiebaut, T. Tsuruo, H. Hamada, M.M. Gottesman, I. Pastan, and M.C. Willingham Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues Proc Natl Acad Sci U S A 84 21 1987 7735 7738
5. M. Maliepaard, G.L. Scheffer, I.F. Faneyte, M.A. van Gastelen, A.C. Pijnenborg, and A.H. Schinkel Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues Cancer Res 61 8 2001 3458 3464 (Pubitemid 32695041)
6. C.F. Higgins ABC transporters: from microorganisms to man Annu Rev Cell Biol 8 1992 67 113 (Pubitemid 23000992)
7. S.F. Zhou Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition Xenobiotica 38 7-8 2008 802 832
8. M.F. Rosenberg, A.B. Kamis, R. Callaghan, C.F. Higgins, and R.C. Ford Three-dimensional structures of the mammalian multidrug resistance P-glycoprotein demonstrate major conformational changes in the transmembrane domains upon nucleotide binding J Biol Chem 278 10 2003 8294 8299 (Pubitemid 36800576)
9. A.B. Shapiro, and V. Ling Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities Eur J Biochem 250 1 1997 130 137 (Pubitemid 27504592)
10. C. Martin, G. Berridge, C.F. Higgins, and R. Callaghan The multi-drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P-glycoprotein by an allosteric interaction Br J Pharmacol 122 4 1997 765 771 (Pubitemid 27453104)
11. Y.J. Lee, H. Kusuhara, J.W. Jonker, A.H. Schinkel, and Y. Sugiyama Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein J Pharmacol Exp Ther 312 1 2005 44 52 (Pubitemid 40096451)
12. R.J. Raggers, A. van Helvoort, R. Evers, and G. van Meer The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane J Cell Sci 112 Pt 3 1999 415 422 (Pubitemid 29080663)
13. D. Yeboah, M. Sun, J. Kingdom, D. Baczyk, S.J. Lye, and S.G. Matthews Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor Can J Physiol Pharmacol 84 12 2006 1251 1258 (Pubitemid 46707373)
14. U. Henriksen, U. Gether, and T. Litman Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2 J Cell Sci 118 Pt 7 2005 1417 1426 (Pubitemid 40585122)
15. R.W. Robey, K.K. To, O. Polgar, M. Dohse, P. Fetsch, and M. Dean ABCG2: a perspective Adv Drug Deliv Rev 61 1 2009 3 13
16. A.H. Schinkel, and J.W. Jonker Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview Adv Drug Deliv Rev 55 1 2003 3 29 (Pubitemid 36078452)
17. O. Polgar, R.W. Robey, and S.E. Bates ABCG2: structure, function and role in drug response Expert Opin Drug Metab Toxicol 4 1 2008 1 15
18. X.B. Chang A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1 Cancer Metastasis Rev 26 1 2007 15 37
19. M. Nagashige, F. Ushigome, N. Koyabu, K. Hirata, M. Kawabuchi, and T. Hirakawa Basal membrane localization of MRP1 in human placental trophoblast Placenta 24 10 2003 951 958 (Pubitemid 37321810)
20. M.V. St-Pierre, M.A. Serrano, R.I. Macias, U. Dubs, M. Hoechli, and U. Lauper Expression of members of the multidrug resistance protein family in human term placenta Am J Physiol Regul Integr Comp Physiol 279 4 2000 R1495 R1503
21. M. Sun, J. Kingdom, D. Baczyk, S.J. Lye, S.G. Matthews, and W. Gibb Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation Placenta 27 6-7 2006 602 609
22. S. Gil, R. Saura, F. Forestier, and R. Farinotti P-glycoprotein expression of the human placenta during pregnancy Placenta 26 2-3 2005 268 270 (Pubitemid 40247016)
23. A.A. Mathias, J. Hitti, and J.D. Unadkat P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages Am J Physiol Regul Integr Comp Physiol 289 4 2005 R963 R969
24. H.E. Meyer zu Schwabedissen, A. Dreisbach, E. Hammer, C. Fusch, M. Hecker, and U. Volker Direct mass spectrometric identification of ABCB1 (P-glycoprotein/MDR1) from the apical membrane fraction of human placenta using fourier transform ion cyclotron mass spectrometry Pharmacogenet Genomics 16 6 2006 385 389 (Pubitemid 43804796)
25. M.A. Serrano, R.I. Macias, O. Briz, M.J. Monte, A.G. Blazquez, and C. Williamson Expression in human trophoblast and choriocarcinoma cell lines, BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like excretory function of the placenta Placenta 28 2-3 2007 107 117 (Pubitemid 44914531)
26. K.W. Scotto Transcriptional regulation of ABC drug transporters Oncogene 22 47 2003 7496 7511 (Pubitemid 37487172)
27. M.J. Madden, C.S. Morrow, M. Nakagawa, M.E. Goldsmith, C.R. Fairchild, and K.H. Cowan Identification of 5' and 3' sequences involved in the regulation of transcription of the human mdr1 gene in vivo J Biol Chem 268 11 1993 8290 8297 (Pubitemid 23120420)
28. R. Sundseth, G. MacDonald, J. Ting, and A.C. King DNA elements recognizing NF-Y and Sp1 regulate the human multidrug-resistance gene promoter Mol Pharmacol 51 6 1997 963 971 (Pubitemid 27249129)
29. K.J. Bailey-Dell, B. Hassel, L.A. Doyle, and D.D. Ross Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene Biochim Biophys Acta 1520 3 2001 234 241 (Pubitemid 32868794)
30. K.V. Chin, K. Ueda, I. Pastan, and M.M. Gottesman Modulation of activity of the promoter of the human MDR1 gene by Ras and p53 Science 255 5043 1992 459 462
31. U. Jeschke, B. Schiessl, I. Mylonas, S. Kunze, C. Kuhn, and S. Schulze Expression of the proliferation marker Ki-67 and of p53 tumor protein in trophoblastic tissue of preeclamptic, HELLP, and intrauterine growth-restricted pregnancies Int J Gynecol Pathol 25 4 2006 354 360 (Pubitemid 44651767)
32. P.J. Daschner, H.P. Ciolino, C.A. Plouzek, and G.C. Yeh Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells Breast Cancer Res Treat 53 3 1999 229 240 (Pubitemid 29209892)
33. R. Kim, and W.T. Beck Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26 Cancer Res 54 18 1994 4958 4966
34. L.D. Coles, I.J. Lee, P.J. Voulalas, and N.D. Eddington Estradiol and progesterone-mediated regulation of P-gp in P-gp overexpressing cells (NCI-ADR-RES) and placental cells (JAR) Mol Pharm 6 6 2009 1816 1825
35. D.A. Evseenko, J.W. Paxton, and J.A. Keelan Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors Drug Metab Dispos 35 4 2007 595 601 (Pubitemid 46513262)
36. H. Wang, E.W. Lee, L. Zhou, P.C. Leung, D.D. Ross, and J.D. Unadkat Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells Mol Pharmacol 73 3 2008 845 854 (Pubitemid 351397889)
37. H. Wang, L. Zhou, A. Gupta, R.R. Vethanayagam, Y. Zhang, and J.D. Unadkat Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells Am J Physiol Endocrinol Metab 290 5 2006 E798 E807
38. A.L. Fowden, J. Li, and A.J. Forhead Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance? Proc Nutr Soc 1998 113 122 (Pubitemid 128736203)
39. V.S. Narang, C. Fraga, N. Kumar, J. Shen, S. Throm, and C.F. Stewart Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier Am J Physiol Cell Physiol 295 2 2008 C440 C450
40. M. Iqbal, W. Gibb, and S.G. Matthews Corticosteroid regulation of P-glycoprotein in the developing blood-brain barrier Endocrinology 152 3 2011 1067 1079
41. P. Pavek, L. Cerveny, L. Svecova, M. Brysch, A. Libra, and R. Vrzal Examination of glucocorticoid receptor alpha-mediated transcriptional regulation of P-glycoprotein, CYP3A4, and CYP2C9 genes in placental trophoblast cell lines Placenta 2007 1004 1011 (Pubitemid 47355238)
42. P.J. Mark, S. Augustus, J.L. Lewis, D.P. Hewitt, and B.J. Waddell Changes in the placental glucocorticoid barrier during rat pregnancy: impact on placental corticosterone levels and regulation by progesterone Biol Reprod 80 6 2009 1209 1215
43. S. Petropoulos, W. Gibb, and S.G. Matthews Effect of glucocorticoids on regulation of placental multidrug resistance phosphoglycoprotein (P-gp) in the mouse Placenta 31 9 2010 803 810
44. S. Petropoulos, W. Gibb, and S.G. Matthews Glucocorticoid regulation of placental breast cancer resistance protein (bcrp1) in the mouse Reprod Sci 2011 631 639
45. X. Wang, C.I. Rousset, H. Hagberg, and C. Mallard Lipopolysaccharide- induced inflammation and perinatal brain injury Semin Fetal Neonatal Med 11 5 2006 343 353 (Pubitemid 44038704)
46. M. Sukhai, A. Yong, A. Pak, and M. Piquette-Miller Decreased expression of P-glycoprotein in interleukin-1beta and interleukin-6 treated rat hepatocytes Inflamm Res 50 7 2001 362 370 (Pubitemid 32675398)
47. V. Petrovic, and M. Piquette-Miller Impact of polyinosinic/polycytidylic acid on placental and hepatobiliary drug transporters in pregnant rats Drug Metab Dispos 38 10 2010 1760 1766
48. M.C. Zatelli, D. Mole, F. Tagliati, M. Minoia, M.R. Ambrosio, and E. degli Uberti Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kappaB Cell Oncol 31 6 2009 457 465
49. N.J. Combates, R.W. Rzepka, Y.N. Chen, and D. Cohen NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter J Biol Chem 269 47 1994 29715 29719 (Pubitemid 24365130)
50. G.L. Semenza Hypoxia-inducible factor 1: master regulator of O2 homeostasis Curr Opin Genet Dev 8 5 1998 588 594 (Pubitemid 28477364)
51. M.G. Tuuli, M.S. Longtine, and D.M. Nelson Review: oxygen and trophoblast biology-a source of controversy Placenta 32 Suppl. 2 2011 S109 S118
52. C.W. Mason, I.A. Buhimschi, C.S. Buhimschi, Y. Dong, C.P. Weiner, and P.W. Swaan ATP-binding cassette transporter expression in human placenta as a function of pregnancy condition Drug Metab Dispos 39 6 2011 1000 1007
53. J.M. Brown, and A.J. Giaccia The unique physiology of solid tumors: opportunities (and problems) for cancer therapy Cancer Res 58 7 1998 1408 1416 (Pubitemid 28193601)
54. S. Jin, and K.W. Scotto Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y Mol Cell Biol 18 7 1998 4377 4384 (Pubitemid 28287960)
55. M. Chen, X. Xue, F. Wang, Y. An, D. Tang, and Y. Xu Expression and promoter methylation analysis of ATP-binding cassette Oncol Rep 2011
56. E. Lee, M.K. Maneno, L. Smith, S.R. Weiss, I.H. Zuckerman, and A.K. Wutoh National patterns of medication use during pregnancy Pharmacoepidemiol Drug Saf 15 8 2006 537 545 (Pubitemid 44336268)
57. S.E. Andrade, M.A. Raebel, A.N. Morse, R.L. Davis, K.A. Chan, and J.A. Finkelstein Use of prescription medications with a potential for fetal harm among pregnant women Pharmacoepidemiol Drug Saf 15 8 2006 546 554 (Pubitemid 44336269)
58. S.E. Andrade, J.H. Gurwitz, R.L. Davis, K.A. Chan, J.A. Finkelstein, and K. Fortman Prescription drug use in pregnancy Am J Obstet Gynecol 191 2 2004 398 407 (Pubitemid 39178690)
59. L.S. Hodge, and T.S. Tracy Alterations in drug disposition during pregnancy: implications for drug therapy Expert Opin Drug Metab Toxicol 3 4 2007 557 571 (Pubitemid 351324964)
60. G.C. Liggins, and R.N. Howie A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants Pediatrics 50 4 1972 515 525
61. F. Elahian, F. Kalalinia, and J. Behravan Dexamethasone downregulates BCRP mRNA and protein expression in breast cancer cell lines Oncol Res 18 1 2009 9 15
62. J. Evans, J. Heron, H. Francomb, S. Oke, and J. Golding Cohort study of depressed mood during pregnancy and after childbirth BMJ 323 7307 2001 257 260 (Pubitemid 32729111)
63. L. Bonari, N. Pinto, E. Ahn, A. Einarson, M. Steiner, and G. Koren Perinatal risks of untreated depression during pregnancy Can J Psychiatry 49 11 2004 726 735 (Pubitemid 40100521)
64. J.S. Wang, H.J. Zhu, B.B. Gibson, J.S. Markowitz, J.L. Donovan, and C.L. DeVane Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein Biol Pharm Bull 31 2 2008 231 234 (Pubitemid 351198395)
65. M. Uhr, T. Steckler, A. Yassouridis, and F. Holsboer Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption Neuropsychopharmacology 22 4 2000 380 387 (Pubitemid 30105766)
66. J. Weiss, S.M. Dormann, M. Martin-Facklam, C.J. Kerpen, N. Ketabi-Kiyanvash, and W.E. Haefeli Inhibition of P-glycoprotein by newer antidepressants J Pharmacol Exp Ther 305 1 2003 197 204 (Pubitemid 36373851)
67. M. Tuccori, A. Testi, L. Antonioli, M. Fornai, S. Montagnani, and N. Ghisu Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review Clin Ther 31 Pt 1 2009 1426 1453
68. C.D. Chambers, K.A. Johnson, L.M. Dick, R.J. Felix, and K.L. Jones Birth outcomes in pregnant women taking fluoxetine N Engl J Med 335 14 1996 1010 1015 (Pubitemid 26338730)
69. A. Ben-Haroush, Y. Yogev, and M. Hod Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes Diabet Med 2004 103 113 (Pubitemid 38221808)
70. M.E. Moretti, M. Rezvani, and G. Koren Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes Ann Pharmacother 2008 483 490 (Pubitemid 351521961)
71. O. Langer, D.L. Conway, M.D. Berkus, E.M. Xenakis, and O. Gonzales A comparison of glyburide and insulin in women with gestational diabetes mellitus N Engl J Med 2000 1134 1138
72. C. Gedeon, J. Behravan, G. Koren, and M. Piquette-Miller Transport of glyburide by placental ABC transporters: implications in fetal drug exposure Placenta 2006 1096 1102 (Pubitemid 44400512)
73. A. Gulati, and P.M. Gerk Role of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancy J Pharm Sci 98 7 2009 2317 2335
74. M. Mirochnick Antiretroviral pharmacology in pregnant women and their newborns Ann N Y Acad Sci 918 2000 287 297
75. M.T. Huisman, J.W. Smit, and A.H. Schinkel Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors AIDS 14 3 2000 237 242 (Pubitemid 30132917)
76. D. Beghin, F. Forestier, M.S. Noel-Hudson, L. Gavard, J. Guibourdenche, and R. Farinotti Modulation of endocrine and transport functions in human trophoblasts by saquinavir and nelfinavir Eur J Obstet Gynecol Reprod Biol 152 1 2010 55 59
77. R.E. Bawdon The ex vivo human placental transfer of the anti-HIV nucleoside inhibitor abacavir and the protease inhibitor amprenavir Infect Dis Obstet Gynecol 6 6 1998 244 246 (Pubitemid 29066601)
78. Y.-H. Li, Y.-H. Wang, Y. Li, and L. Yang MDR1 gene polymorphisms and clinical relevance Acta Genetica Sinica 2006 93 104 (Pubitemid 43267147)
79. J.R. Hutson, G. Koren, and S.G. Matthews Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology Placenta 2010 351 357
80. S.J. Hemauer, T.N. Nanovskaya, S.Z. Abdel-Rahman, S.L. Patrikeeva, G.D.V. Hankins, and M.S. Ahmed Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms Biochem Pharmacol 2010 921 925
81. M. Hitzl, E. Schaeffeler, B. Hocher, T. Slowinski, H. Halle, and M. Eichelbaum Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1) Pharmacogenetics 2004 309 318 (Pubitemid 38638918)
82. H. Takane, D. Kobayashi, T. Hirota, J. Kigawa, N. Terakawa, and K. Otsubo Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene J Pharmacol Exp Ther 2004 1179 1187 (Pubitemid 39612726)
83. D. Kobayashi, I. Ieiri, T. Hirota, H. Takane, S. Maegawa, and J. Kigawa Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta Drug Metab Dispos 2005 94 101 (Pubitemid 40023519)
84. A. Sparreboom, W.J. Loos, H. Burger, T.M. Sissung, J. Verweij, and W.D. Figg Effect of ABCG2 genotype on the oral bioavailability of topotecan Cancer Biol Ther 2005 650 658
85. F.A. de Jong, S. Marsh, R.H.J. Mathijssen, C. King, J. Verweij, and A. Sparreboom ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition Clin Cancer Res 2004 5889 5894 (Pubitemid 39180970)
86. Y. Imai, M. Nakane, K. Kage, S. Tsukahara, E. Ishikawa, and T. Tsuruo C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance Mol Cancer Ther 2002 611 616
87. A.M. Garcia, T. Fletcher, F.G. Benavides, and E. Orts Parental agricultural work and selected congenital malformations Am J Epidemiol 149 1 1999 64 74 (Pubitemid 29028863)